Similarly, CD58 correlated with MSI in breast invasive carcinoma (BRCA), CESC, KICH, LUAD, ovarian serous cystadenocarcinoma (OV), pheochromocytoma and paraganglioma (PCPG), THCA, and UCEC. Here, CD58 is linked to ovarian serous cystadenocarcinoma.